SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-051057
Filing Date
2020-09-17
Accepted
2020-09-17 20:27:30
Documents
2
Period of Report
2020-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10199
2 POA DOCUMENT poa.txt EX-24.3_937718 2101
  Complete submission text file 0001209191-20-051057.txt   13811
Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 98195-2141
Business Address
KAWAS LEEN (Reporting) CIK: 0001822491 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 201182461